Wesfarmers moves closer to API ownership.

Retail conglomerate, Wesfarmers, is expecting to complete its acquisition of pharmacy wholesaler, Australian Pharmaceutical Industries (API) within the first quarter of the 2022 calendar year. 

In a statement to the Australian Securities Exchange (ASX), API confirmed the company had entered into a Scheme Implementation Deed (SID) this morning. 

The move follows Sigma Healthcare’s decision to withdraw its merger proposal last week (PD 05 November), and the competition of Wesfarmer's due diligence process.

Under the SID, Wesfarmers will acquire 100% of the shares in API it does not already own for cash consideration of $1.55 per share. 

See today’s edition of Pharmacy Daily for more. 

advertimg.png

This Pharmacy Daily breaking news is brought to you by  JPH Group

To ensure you continue to receive email from Pharmacy Daily reliably please add info@pharmacydaily.com.au to your 'Safe Senders' list and set images to always display.

To forward this email to a friend click here.  To receive your own copy of Pharmacy Daily sign up here.
To modify subscription details click here.  To unsubscribe click here.

facebook.com/pharmacydaily  Follow us on Instagram  PD on LinkedIn  Follow us on Twitter  Pharmacy Daily TV

The Therapeutic Goods Advertising Code 2015 requires strict compliance. View the code here.

Pharmacy Daily - a division of Business Publishing Group
PO Box 1010 Epping NSW Australia 1710
Level 2, Suite 1 64 Talavera Rd Macquarie Park NSW 2113
Phone: 1300 799 220 ( 61 2 8007 6760)
Email: info@pharmacydaily.com.au